Purchase Order 75N95C21P00022

This is a federal contract award to Activx Biosciences, Inc. by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the U.S. Department of Health and Human Services. The $10,850 Firm Fixed Price contract is a replacement award for a previous contract (75N94020P00619) and has a completion date of September 30, 2020. Activx Biosciences is a foreign-owned, for-profit biopharmaceutical company that specializes in drug discovery and development services, with...

This is a $68,115.00 Firm Fixed Price contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Atelerix Life Sciences Inc. for a Phase 1A clinical trial of the novel small molecule ATLX-0199. The objective of the trial is to evaluate the compound in 30 normal healthy subjects. This contract is not set aside and is part of the ATELERIX - PROOF-OF-CONCEPT CLINICAL TRIAL FOR A NOVEL RESPIRATORY STIMULANT major program. The work will be performed...

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $2.1 million firm fixed price purchase order to Avista Pharma Solutions, Inc., doing business as Cambrex, for the acquisition of two kilograms of cGMP-grade GS-441524 drug substance with an option for two additional kilograms. The drug substance will support preclinical and Phase I clinical studies by the NIH to evaluate GS-441524's potential as a COVID-19 treatment through assessing its safety,...

This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Bio-Active Company LIMITED, a for-profit limited liability company, for the acquisition of lab reagents for whole genome sequencing with Illumina instruments on behalf of the CDC's Division of Global Health Protection (DGHP) in Thailand. The contract, valued at $81,470.59, has an ultimate completion date of October 31, 2024. Bio-Active Company LIMITED has a history of delivering genetic...

This is a $90,075 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to American Biochemicals Inc. The contract is for the synthesis of approximately 50 analogs of the small molecule compound metarrestin, which is being developed as an anti-metastasis agent for pancreatic cancer. The goal is to reduce the brain exposure of the compounds while maintaining their...

This is a $13,200 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Dexorgen Inc., doing business as Codex Biosolutions Inc. The contract is for the development and optimization of antagonist assays in cells expressing different variants of the ACVR1 gene. Codex Biosolutions is a minority-owned small disadvantaged business located in Gaithersburg, Maryland that...

<p>This is a $4,075,691.59 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Genway Biotech, LLC, a small business. The contract is for a &quot;PATH FIELD STUDY ANALYTES BIOMARKERS TO BE ANALYZED&quot; requirement, with a period of performance ending on May 10, 2020. Genway Biotech, LLC is a subsidiary of Aviva Systems Biology Corporation. The contract was set aside for total small business participation.</p>

The Department of Health and Human Services Food and Drug Administration awarded a $17,500 firm fixed price purchase order to Life Technologies Corporation for the purchase of anti-anthrax toxin antibody Obiltoxaximab in single glass vials at a concentration of 10 mg/ml. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation Financial Services Division and will deliver the requested product from its facility in Silver Spring, Maryland by November 9, 2023 to support the...

Akoya Biosciences, doing business as Phenoptics, was awarded a $38,335.10 firm fixed price call against the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 blanket purchase agreement for the delivery of unspecified products or services. Place of performance will be in Marlborough, Massachusetts. No set-aside provisions were applied to this award, which is anticipated for completion by August 30, 2022. As the awarding agency, Veterans Affairs...

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $3.86 million firm fixed price purchase order to Molecular Devices LLC for the acquisition of five Molecular Devices ImageXpress Confocal High-Content Imaging Systems, one FLIPR Penta high-throughput cellular screening system, along with associated software, services, consumables, installation, training, customization, maintenance, and technical support. The products and services are to support the...